Van Swearingen, Amanda E. D.
Siegel, Marni B.
Deal, Allison M.
Sambade, Maria J.
Hoyle, Alan
Hayes, D. Neil
Jo, Heejoon
Little, Paul
Dees, Elizabeth Claire
Muss, Hyman
Jolly, Trevor
Zagar, Timothy M.
Patel, Nirali
Miller, C. Ryan
Parker, Joel S.
Smith, J. Keith
Fisher, Julie
Shah, Nikita
Nabell, Lisle
Nanda, Rita
Dillon, Patrick
Abramson, Vandana
Carey, Lisa A.
Anders, Carey K. http://orcid.org/0000-0001-9165-4074
Funding for this research was provided by:
National Institutes of Health (F30-CA200345, 5-K23-CA157728-05)
Damon Runyon Cancer Research Foundation (CI-64-12)
North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill (NCI 5U10CA181009)
Article History
Received: 4 June 2018
Accepted: 7 June 2018
First Online: 25 June 2018
Compliance with Ethical Standards
:
: Carey K. Anders is an uncompensated consultant/advisory board member for Novartis, Sanofi, toBBB, Angiochem, Merrimack, Lily, Genentech, Nektar, and Kadmon, receives unrelated research funding from Novartis, Sanofi, toBBB, Angiochem, Merrimack, PUMA, Lily, Merck, Oncothyreon, Cascadian, Nektar, and Tesaro, and receives honoraria for UptoDate and Jones and Bartlett Publishing. Rita Nanda is a consultant/advisory board member for AstraZeneca, Celgene, Genentech, Merck, Pfizer, Puma, and Syndax. Nikita Shah is a consultant for Novartis. The other authors declare they have no conflicts of interest.
: This manuscript complies with all current laws of the country in which they were performed. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained by all individual participants included in the study.
: This article does not contain any studies with animals performed by any of the authors.